Skip to main content
. 2022 Sep 8;26:44. doi: 10.1186/s40824-022-00290-6

Fig. 3.

Fig. 3

Distant tumor inhibition by tri-modal TAT/CDT/ICB combined therapy. (a) Schematic diagram of targeted alpha therapy plus anti-PD-L1 to suppress distant tumor growth. (b-d) Primary and distant tumor growth curves (b-c) and survival rates (d) of 4 T1 tumor-bearing mice after various treatments. Error bars represent mean ± s.d. (n = 5). (e-g) Primary and distant tumor growth curves (e-f) and survival rates. (g) of CT26 tumor-bearing mice after various treatments. Error bars represent mean ± s.d. (n = 5)